$RKDA
Arcadia Biosciences, Inc.

2018 Q2 Form 10-Q Financial Statement

#000156459018020562 Filed on August 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $436.0K $991.0K
YoY Change -56.0% 1424.62%
Cost Of Revenue $270.0K $120.0K
YoY Change 125.0% 242.86%
Gross Profit $170.0K $880.0K
YoY Change -80.68% 2833.33%
Gross Profit Margin 38.99% 88.8%
Selling, General & Admin $2.949M $2.943M
YoY Change 0.2% 6.67%
% of Gross Profit 1734.71% 334.43%
Research & Development $1.794M $1.670M
YoY Change 7.43% -24.64%
% of Gross Profit 1055.29% 189.77%
Depreciation & Amortization $50.00K $70.00K
YoY Change -28.57% -12.5%
% of Gross Profit 29.41% 7.95%
Operating Expenses $5.014M $4.728M
YoY Change 6.05% -5.63%
Operating Profit -$4.578M -$3.737M
YoY Change 22.5% -12.87%
Interest Expense $0.00 $365.0K
YoY Change -100.0% 11.62%
% of Operating Profit
Other Income/Expense, Net $94.00K $104.0K
YoY Change -9.62% 36.84%
Pretax Income -$6.658M -$3.998M
YoY Change 66.53% -11.94%
Income Tax $11.00K $8.000K
% Of Pretax Income
Net Earnings -$6.669M -$4.010M
YoY Change 66.31% -11.89%
Net Earnings / Revenue -1529.59% -404.64%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.015M -$1.883M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.60M $44.18M
YoY Change -35.26% -18.53%
Cash & Equivalents $9.667M $13.44M
Short-Term Investments $18.93M $30.74M
Other Short-Term Assets $800.0K $1.480M
YoY Change -45.95% 6.47%
Inventory $280.0K $290.0K
Prepaid Expenses
Receivables $290.0K $570.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $29.97M $46.52M
YoY Change -35.58% -17.22%
LONG-TERM ASSETS
Property, Plant & Equipment $270.0K $420.0K
YoY Change -35.71% -34.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $900.0K $1.500M
YoY Change -40.0% -23.86%
Total Long-Term Assets $1.160M $1.910M
YoY Change -39.27% -79.92%
TOTAL ASSETS
Total Short-Term Assets $29.97M $46.52M
Total Long-Term Assets $1.160M $1.910M
Total Assets $31.13M $48.43M
YoY Change -35.72% -26.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.00K $30.00K
YoY Change -66.67% 50.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $4.170M
YoY Change -100.0%
Total Short-Term Liabilities $2.920M $6.690M
YoY Change -56.35% 64.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $21.06M
YoY Change -100.0% -15.85%
Other Long-Term Liabilities $20.08M $5.920M
YoY Change 239.19% 97.33%
Total Long-Term Liabilities $20.08M $26.98M
YoY Change -25.57% -3.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.920M $6.690M
Total Long-Term Liabilities $20.08M $26.98M
Total Liabilities $23.00M $33.67M
YoY Change -31.69% -2.18%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.130M $14.76M
YoY Change
Total Liabilities & Shareholders Equity $31.13M $48.43M
YoY Change -35.72% -26.3%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$6.669M -$4.010M
YoY Change 66.31% -11.89%
Depreciation, Depletion And Amortization $50.00K $70.00K
YoY Change -28.57% -12.5%
Cash From Operating Activities -$4.300M -$4.390M
YoY Change -2.05% 10.03%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$18.91M $10.26M
YoY Change -284.31% 489.66%
Cash From Investing Activities -$18.95M $10.27M
YoY Change -284.52% 511.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.50M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -4.300M -4.390M
Cash From Investing Activities -18.95M 10.27M
Cash From Financing Activities 12.50M 0.000
Net Change In Cash -10.75M 5.880M
YoY Change -282.82% -370.97%
FREE CASH FLOW
Cash From Operating Activities -$4.300M -$4.390M
Capital Expenditures -$40.00K $0.00
Free Cash Flow -$4.260M -$4.390M
YoY Change -2.96% 11.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2038000
CY2018Q2 rkda Common Stock Warrant Liability
CommonStockWarrantLiability
17079000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
436000
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
991000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
650000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2009000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3190000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2949000
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2943000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5570000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
5014000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
4728000
us-gaap Operating Expenses
OperatingExpenses
9067000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4578000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3737000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8417000
CY2017Q2 us-gaap Interest Expense
InterestExpense
365000
us-gaap Interest Expense
InterestExpense
704000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
94000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
104000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
132000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000
rkda Initial Loss On Common Stock Warrant And Common Stock Adjustment Feature Liabilities
InitialLossOnCommonStockWarrantAndCommonStockAdjustmentFeatureLiabilities
4000000
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
535000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2435000
CY2018Q2 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
1639000
us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
2543000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6658000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3998000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-6669000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.02
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.88
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3307667
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2133241
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6669000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3999000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17283000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
22198000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
24000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1474000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-15707000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
963000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
526000
rkda Adjustments To Additional Paid In Capital Reclassification Of Common Stock To Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfCommonStockToLiability
8378000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
98000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
146000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
27000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
65000
us-gaap Share Based Compensation
ShareBasedCompensation
656000
us-gaap Share Based Compensation
ShareBasedCompensation
760000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
99000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1051000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
83000
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
102000
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-43000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-226000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-140000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
245000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
603000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
327000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-52000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-525000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-17000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-197000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-274000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6918000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8917000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
68000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
18908000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19405000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3900000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
39785000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15067000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20326000
rkda Proceeds From Issuance Of Common Stock And Warrants From Purchase Agreement
ProceedsFromIssuanceOfCommonStockAndWarrantsFromPurchaseAgreement
10000000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1305000
rkda Proceeds From Issuance Of Common Stock And Warrants From Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromOffering
14000000
rkda Payments Of Offering Costs
PaymentsOfOfferingCosts
1134000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
966000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22527000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
542000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11425000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2013000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13438000
us-gaap Interest Paid Net
InterestPaidNet
599000
us-gaap Income Taxes Paid
IncomeTaxesPaid
24000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
rkda Proceeds From Sale Of Fixed Assets Included Prepaid Expenses And Other Current Assets
ProceedsFromSaleOfFixedAssetsIncludedPrepaidExpensesAndOtherCurrentAssets
1000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
46000
rkda Warrant Issued Included In Offering Costs
WarrantIssuedIncludedInOfferingCosts
526000
rkda Warrants Issued Charged Against Equity
WarrantsIssuedChargedAgainstEquity
239000
rkda Adjustments To Additional Paid In Capital Reclassification Of Common Stock Warrant To Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfCommonStockWarrantToLiability
8378000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2000
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Arizona
rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2017Q2 rkda Reduction In Common Stock Shares Authorized
ReductionInCommonStockSharesAuthorized
150000000
CY2017Q2 rkda Reduction In Common Stock Shares Authorized
ReductionInCommonStockSharesAuthorized
400000000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:20
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000
CY2018Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14000000
CY2018Q2 us-gaap Inventory Write Down
InventoryWriteDown
177000
us-gaap Inventory Write Down
InventoryWriteDown
177000
CY2017Q2 us-gaap Inventory Write Down
InventoryWriteDown
0
us-gaap Inventory Write Down
InventoryWriteDown
0
CY2018Q2 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
45000
CY2017Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
45000
CY2018Q2 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1126000
CY2017Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1352000
CY2018Q2 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
1171000
CY2017Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
1397000
CY2018Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
28495000
CY2018Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2018Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
28495000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
12842000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
12841000
CY2018Q2 rkda Available For Sale Securities Continuous Unrealized Loss Position For More Than Three Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionForMoreThanThreeMonthsAccumulatedLoss
0
CY2018Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17079000
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12841000
CY2018Q2 us-gaap Interest Expense
InterestExpense
0
us-gaap Variable Interest Entity Terms Of Arrangements
VariableInterestEntityTermsOfArrangements
Both the Company and Bioceres incur expenses in support of specific activities, as agreed upon by joint work plans, which apply fair market value to each partner’s activities. Unequal contributions of services are equalized by the partners through cash payments. Verdeca is not the primary obligor for these activities performed by the Company or Bioceres.
CY2018Q2 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
227000
CY2017Q2 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
135000
us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
513000
us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
224000
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
0
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
0
rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
us-gaap Interest Expense
InterestExpense
0
rkda Period Of Trading Days Taken For Calculation Of Volume Weighted Average Price
PeriodOfTradingDaysTakenForCalculationOfVolumeWeightedAveragePrice
P3D
rkda Percentage Of Volume Weighted Average Price Of Common Stock
PercentageOfVolumeWeightedAveragePriceOfCommonStock
0.80
rkda Percentage Of Volume Weighted Average Price Of Warrant
PercentageOfVolumeWeightedAveragePriceOfWarrant
1.10
CY2018Q2 us-gaap Share Price
SharePrice
32.52
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
32.21
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.69
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
64.20
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
89.94
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5000
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
330.40
CY2018Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
982080
CY2018Q2 rkda Class Of Warrant Or Right Number Of Securities Called By All Warrants Or Rights Issued To Date
ClassOfWarrantOrRightNumberOfSecuritiesCalledByAllWarrantsOrRightsIssuedToDate
1282832
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.7258
CY2018Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
4000000
CY2018Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
15900000
CY2018Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1900000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
50000000
CY2018Q2 rkda Fair Value Of Common Stock Warrants At Inception
FairValueOfCommonStockWarrantsAtInception
9000000
CY2018Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
197000000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
288129
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
44910
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44354
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5426
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
283259
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
277258
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
132977
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.62
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
18.27
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
21.73
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3109946
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
370680

Files In Submission

Name View Source Status
0001564590-18-020562-index-headers.html Edgar Link pending
0001564590-18-020562-index.html Edgar Link pending
0001564590-18-020562.txt Edgar Link pending
0001564590-18-020562-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-10q_20180630.htm Edgar Link pending
rkda-20180630.xml Edgar Link completed
rkda-20180630.xsd Edgar Link pending
rkda-20180630_cal.xml Edgar Link unprocessable
rkda-20180630_def.xml Edgar Link unprocessable
rkda-20180630_lab.xml Edgar Link unprocessable
rkda-20180630_pre.xml Edgar Link unprocessable
rkda-ex311_9.htm Edgar Link pending
rkda-ex312_8.htm Edgar Link pending
rkda-ex321_6.htm Edgar Link pending
rkda-ex322_7.htm Edgar Link pending
Show.js Edgar Link pending